Advanced search
Publication Cover
International Journal of Neuroscience Volume 122, 2012 - Issue 7
Submit an article Journal homepage
576
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Indirect Comparisons of Adverse Events and Dropout Rates in Early Parkinson's Disease Trials of Pramipexole, Ropinirole, and Rasagiline

Francisco J. ZagmuttEpiX Analytics, Boulder, CO, USACorrespondence[email protected]
[email protected]
&
Marcy L. TarrantsTeva Neuroscience, Kansas City, MO, USA
Pages 345-353 | Received 31 Aug 2011, Published online: 23 Mar 2012

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Andrew Ridder & Kelvin L Chou. (2016) Managing fatigue in patients with Parkinson's disease: a patient-focused perspective. Journal of Parkinsonism and Restless Legs Syndrome 6, pages 65-72.
Read now
Rukmini Mridula Kandadai, Shaik Afshan Jabeen, Meena A Kanikannan & Rupam Borgohain. (2014) Safinamide for the treatment of Parkinson’s disease. Expert Review of Clinical Pharmacology 7:6, pages 747-759.
Read now
Michele A Faulkner. (2014) Safety overview of FDA-approved medications for the treatment of the motor symptoms of Parkinson’s disease. Expert Opinion on Drug Safety 13:8, pages 1055-1069.
Read now
Julián Solís-García del Pozo, Sara Mínguez-Mínguez, Piet WJ de Groot & Joaquín Jordán. (2013) Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease. Expert Opinion on Drug Safety 12:4, pages 479-486.
Read now

Articles from other publishers (15)

Béla Kiss, István Laszlovszky, Balázs Krámos, András Visegrády, Amrita Bobok, György Lévay, Balázs Lendvai & Viktor Román. (2021) Neuronal Dopamine D3 Receptors: Translational Implications for Preclinical Research and CNS Disorders. Biomolecules 11:1, pages 104.
Crossref
Gustaf J. Wellhagen, Mats O. Karlsson & Maria C. Kjellsson. (2020) Comparison of Precision and Accuracy of Five Methods to Analyse Total Score Data. The AAPS Journal 23:1.
Crossref
Jiali Zhu & Min Chen. (2021) The effect and safety of ropinirole in the treatment of Parkinson disease. Medicine 100:46, pages e27653.
Crossref
Jun Zhu, Min Zhong, Jun Yan, Xu Jiang, Zhuang Wu, Yang Pan, Bo Shen, Lili Zhang, Jingde Dong & Li Zhang. (2020) Nonmotor Symptoms Affect Sleep Quality in Early-Stage Parkinson's Disease Patients With or Without Cognitive Dysfunction. Frontiers in Neurology 11.
Crossref
Laiana A Quagliato, Fiammetta Cosci, Richard I Shader, Edward K Silberman, Vladan Starcevic, Richard Balon, Steven L Dubovsky, Carl Salzman, John H Krystal, Steve J Weintraub, Rafael C Freire & Antonio E Nardi. (2019) Selective serotonin reuptake inhibitors and benzodiazepines in panic disorder: A meta-analysis of common side effects in acute treatment. Journal of Psychopharmacology 33:11, pages 1340-1351.
Crossref
Areti Angeliki Veroniki, Sharon E. Straus, Gerta Rücker & Andrea C. Tricco. (2018) Is providing uncertainty intervals in treatment ranking helpful in a network meta-analysis?. Journal of Clinical Epidemiology 100, pages 122-129.
Crossref
Julianne Stewart, Gail Bachman, Clarissa Cooper, Lianqi Liu, Sonia Ancoli-Israel & Laila Alibiglou. (2018) Circadian dysfunction and fluctuations in gait initiation impairment in Parkinson’s disease. Experimental Brain Research 236:3, pages 655-664.
Crossref
Daniel O. Claassen, Benjamin Carroll, Lisa M. De Boer, Eric Wu, Rajeev Ayyagari, Sanjay Gandhi & David Stamler. (2017) Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease. Journal of Clinical Movement Disorders 4:1.
Crossref
Javier Pagonabarraga, Juan Marín-Lahoz & Jaime Kulisevsky. 2016. Parkinson's Disease. Parkinson's Disease 34 47 .
. 2016. Parkinson's Disease. Parkinson's Disease 1 92 .
Daphne Robakis & Stanley Fahn. (2015) Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson’s Disease. CNS Drugs 29:6, pages 433-441.
Crossref
Maria Mavrikaki, Nicoletta Schintu, George G Nomikos, George Panagis & Per Svenningsson. (2014) Ropinirole regulates emotionality and neuronal activity markers in the limbic forebrain. The International Journal of Neuropsychopharmacology 17:12, pages 1981-1993.
Crossref
James E. Frampton. (2014) Pramipexole Extended-Release: A Review of Its Use in Patients with Parkinson’s Disease. Drugs 74:18, pages 2175-2190.
Crossref
Paul L. McCormack. (2014) Rasagiline: A Review of Its Use in the Treatment of Idiopathic Parkinson’s Disease. CNS Drugs 28:11, pages 1083-1097.
Crossref
Shinichiro Nakajima, Philip Gerretsen, Hiroyoshi Takeuchi, Fernando Caravaggio, Tiffany Chow, Bernard Le Foll, Benoit Mulsant, Bruce Pollock & Ariel Graff-Guerrero. (2013) The potential role of dopamine D3 receptor neurotransmission in cognition. European Neuropsychopharmacology 23:8, pages 799-813.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.